Arecor Therapeutics plc (AREC.L)
GBp 38.0
(3.68%)
GBp 38.0
(3.68%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -4.75 Million GBP | -6.21% |
| 2022 | -4.47 Million GBP | 75.24% |
| 2021 | -18.08 Million GBP | -1902.52% |
| 2020 | -903.11 Thousand GBP | 70.03% |
| 2019 | -3.01 Million GBP | 6.58% |
| 2018 | -3.22 Million GBP | -7092.15% |
| 2017 | -44.84 Thousand GBP | 90.08% |
| 2016 | -452.19 Thousand GBP | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -2.41 Million GBP | 11.07% |
| 2024 Q1 | -2.52 Million GBP | 46.81% |
| 2023 Q4 | -4.75 Million GBP | 2.42% |
| 2023 FY | -4.75 Million GBP | -6.21% |
| 2023 Q3 | -4.87 Million GBP | 24.37% |
| 2023 Q2 | -6.44 Million GBP | 1.77% |
| 2023 Q1 | -6.55 Million GBP | -46.5% |
| 2022 FY | -4.47 Million GBP | 75.24% |
| 2022 Q4 | -4.47 Million GBP | 4.32% |
| 2022 Q3 | -4.67 Million GBP | 65.46% |
| 2022 Q2 | -13.54 Million GBP | 0.93% |
| 2022 Q1 | -13.67 Million GBP | 24.38% |
| 2021 Q3 | -18.21 Million GBP | 16.68% |
| 2021 FY | -18.08 Million GBP | -1902.52% |
| 2021 Q1 | -21.98 Million GBP | -2333.93% |
| 2021 Q2 | -21.85 Million GBP | 0.57% |
| 2021 Q4 | -18.08 Million GBP | 0.69% |
| 2020 Q3 | -1 Million GBP | 54.18% |
| 2020 Q2 | -2.2 Million GBP | -171.58% |
| 2020 Q1 | 3.07 Million GBP | 0.0% |
| 2020 FY | -903.11 Thousand GBP | 70.03% |
| 2020 Q4 | -903.11 Thousand GBP | 10.41% |
| 2019 FY | -3.01 Million GBP | 6.58% |
| 2018 FY | -3.22 Million GBP | -7092.15% |
| 2017 FY | -44.84 Thousand GBP | 90.08% |
| 2016 FY | -452.19 Thousand GBP | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|